Clinical presentation and outcomes of patients with biliary malignancies

The Aga Khan university experience

Shiyam Kumar, Nehal Masood, Asim Jamal Shaikh, Azmina T. Valimuhammad, Ghulam Haider, Amar Lal, Najeeb Niamatullah

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Gall bladder cancer (GBC) is a common malignancy in our country; very limited data exist on this malignancy in Pakistan. Methods: This is a retrospective analysis of all the admitted patients diagnosed with GBC or cholangiocarcinoma in between 1st January 1995 to 31st December 2007. Results: A total of 245 patients were admitted with diagnosis of GBC or cholangiocarcinoma. Sixty seven percent were females. Right hypochondrial pain (70.6%) and jaundice (49.8%) were the commonest symptoms, followed by nausea and vomiting (11.8%), weight loss (13%), fever (18.8%), anorexia (9.8%) and ascites (3.3%). Gall stones were seen in 132 (53.9%) patients. Pathological diagnosis was confirmed in 155 (63.2%) patients, adenocarcinoma (94.83%) being the predominant type. Metastasis was seen in 204 (83.3%) patients, with liver and abdominal lymph nodes being the frequent sites of metastasis. Most of the patients presented to the surgeons (42.9%) and gastroenterologists (35.9%) at their first visit. Only 89 (26.3%) patients were referred to medical oncologists and 42 (16.7%) of the patients actually received chemotherapy. The patients who received chemotherapy cisplatin and gemcitabine demonstrated partial responses (40%). Common bile duct stricture was seen in 78 patients and stenting was successful in 73 patients. Fourteen (5.7%) patients are alive to date, one is receiving chemotherapy, and another is alive with advanced disease while 10 patients had incidental diagnosis after surgery. Of all 53.9% of patients have died and 38% are lost to follow up. Conclusion: Most of the patients with biliary cancers present late with advanced disease at our referral tertiary care hospital. Minority of the patients received chemotherapy and most of responses were observed with cisplatin and gemcitabine combination or capecitbine based therapy.

Original languageEnglish
Pages (from-to)463-466
Number of pages4
JournalAsian Pacific Journal of Cancer Prevention
Volume10
Issue number3
Publication statusPublished - 2009

Fingerprint

Neoplasms
gemcitabine
Gallbladder Neoplasms
Drug Therapy
Cholangiocarcinoma
Cisplatin
Biliary Tract Neoplasms
Neoplasm Metastasis
Lost to Follow-Up
Pakistan
Common Bile Duct
Anorexia
Gallstones
Tertiary Healthcare
Jaundice
Ascites
Tertiary Care Centers
Nausea
Vomiting
Weight Loss

Keywords

  • Clinical details
  • Gallbladder cancer
  • Symptoms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Kumar, S., Masood, N., Shaikh, A. J., Valimuhammad, A. T., Haider, G., Lal, A., & Niamatullah, N. (2009). Clinical presentation and outcomes of patients with biliary malignancies: The Aga Khan university experience. Asian Pacific Journal of Cancer Prevention, 10(3), 463-466.

Clinical presentation and outcomes of patients with biliary malignancies : The Aga Khan university experience. / Kumar, Shiyam; Masood, Nehal; Shaikh, Asim Jamal; Valimuhammad, Azmina T.; Haider, Ghulam; Lal, Amar; Niamatullah, Najeeb.

In: Asian Pacific Journal of Cancer Prevention, Vol. 10, No. 3, 2009, p. 463-466.

Research output: Contribution to journalArticle

Kumar, S, Masood, N, Shaikh, AJ, Valimuhammad, AT, Haider, G, Lal, A & Niamatullah, N 2009, 'Clinical presentation and outcomes of patients with biliary malignancies: The Aga Khan university experience', Asian Pacific Journal of Cancer Prevention, vol. 10, no. 3, pp. 463-466.
Kumar, Shiyam ; Masood, Nehal ; Shaikh, Asim Jamal ; Valimuhammad, Azmina T. ; Haider, Ghulam ; Lal, Amar ; Niamatullah, Najeeb. / Clinical presentation and outcomes of patients with biliary malignancies : The Aga Khan university experience. In: Asian Pacific Journal of Cancer Prevention. 2009 ; Vol. 10, No. 3. pp. 463-466.
@article{4060fe0f325e4d63bd4ce96c7bc58d3c,
title = "Clinical presentation and outcomes of patients with biliary malignancies: The Aga Khan university experience",
abstract = "Background: Gall bladder cancer (GBC) is a common malignancy in our country; very limited data exist on this malignancy in Pakistan. Methods: This is a retrospective analysis of all the admitted patients diagnosed with GBC or cholangiocarcinoma in between 1st January 1995 to 31st December 2007. Results: A total of 245 patients were admitted with diagnosis of GBC or cholangiocarcinoma. Sixty seven percent were females. Right hypochondrial pain (70.6{\%}) and jaundice (49.8{\%}) were the commonest symptoms, followed by nausea and vomiting (11.8{\%}), weight loss (13{\%}), fever (18.8{\%}), anorexia (9.8{\%}) and ascites (3.3{\%}). Gall stones were seen in 132 (53.9{\%}) patients. Pathological diagnosis was confirmed in 155 (63.2{\%}) patients, adenocarcinoma (94.83{\%}) being the predominant type. Metastasis was seen in 204 (83.3{\%}) patients, with liver and abdominal lymph nodes being the frequent sites of metastasis. Most of the patients presented to the surgeons (42.9{\%}) and gastroenterologists (35.9{\%}) at their first visit. Only 89 (26.3{\%}) patients were referred to medical oncologists and 42 (16.7{\%}) of the patients actually received chemotherapy. The patients who received chemotherapy cisplatin and gemcitabine demonstrated partial responses (40{\%}). Common bile duct stricture was seen in 78 patients and stenting was successful in 73 patients. Fourteen (5.7{\%}) patients are alive to date, one is receiving chemotherapy, and another is alive with advanced disease while 10 patients had incidental diagnosis after surgery. Of all 53.9{\%} of patients have died and 38{\%} are lost to follow up. Conclusion: Most of the patients with biliary cancers present late with advanced disease at our referral tertiary care hospital. Minority of the patients received chemotherapy and most of responses were observed with cisplatin and gemcitabine combination or capecitbine based therapy.",
keywords = "Clinical details, Gallbladder cancer, Symptoms",
author = "Shiyam Kumar and Nehal Masood and Shaikh, {Asim Jamal} and Valimuhammad, {Azmina T.} and Ghulam Haider and Amar Lal and Najeeb Niamatullah",
year = "2009",
language = "English",
volume = "10",
pages = "463--466",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "3",

}

TY - JOUR

T1 - Clinical presentation and outcomes of patients with biliary malignancies

T2 - The Aga Khan university experience

AU - Kumar, Shiyam

AU - Masood, Nehal

AU - Shaikh, Asim Jamal

AU - Valimuhammad, Azmina T.

AU - Haider, Ghulam

AU - Lal, Amar

AU - Niamatullah, Najeeb

PY - 2009

Y1 - 2009

N2 - Background: Gall bladder cancer (GBC) is a common malignancy in our country; very limited data exist on this malignancy in Pakistan. Methods: This is a retrospective analysis of all the admitted patients diagnosed with GBC or cholangiocarcinoma in between 1st January 1995 to 31st December 2007. Results: A total of 245 patients were admitted with diagnosis of GBC or cholangiocarcinoma. Sixty seven percent were females. Right hypochondrial pain (70.6%) and jaundice (49.8%) were the commonest symptoms, followed by nausea and vomiting (11.8%), weight loss (13%), fever (18.8%), anorexia (9.8%) and ascites (3.3%). Gall stones were seen in 132 (53.9%) patients. Pathological diagnosis was confirmed in 155 (63.2%) patients, adenocarcinoma (94.83%) being the predominant type. Metastasis was seen in 204 (83.3%) patients, with liver and abdominal lymph nodes being the frequent sites of metastasis. Most of the patients presented to the surgeons (42.9%) and gastroenterologists (35.9%) at their first visit. Only 89 (26.3%) patients were referred to medical oncologists and 42 (16.7%) of the patients actually received chemotherapy. The patients who received chemotherapy cisplatin and gemcitabine demonstrated partial responses (40%). Common bile duct stricture was seen in 78 patients and stenting was successful in 73 patients. Fourteen (5.7%) patients are alive to date, one is receiving chemotherapy, and another is alive with advanced disease while 10 patients had incidental diagnosis after surgery. Of all 53.9% of patients have died and 38% are lost to follow up. Conclusion: Most of the patients with biliary cancers present late with advanced disease at our referral tertiary care hospital. Minority of the patients received chemotherapy and most of responses were observed with cisplatin and gemcitabine combination or capecitbine based therapy.

AB - Background: Gall bladder cancer (GBC) is a common malignancy in our country; very limited data exist on this malignancy in Pakistan. Methods: This is a retrospective analysis of all the admitted patients diagnosed with GBC or cholangiocarcinoma in between 1st January 1995 to 31st December 2007. Results: A total of 245 patients were admitted with diagnosis of GBC or cholangiocarcinoma. Sixty seven percent were females. Right hypochondrial pain (70.6%) and jaundice (49.8%) were the commonest symptoms, followed by nausea and vomiting (11.8%), weight loss (13%), fever (18.8%), anorexia (9.8%) and ascites (3.3%). Gall stones were seen in 132 (53.9%) patients. Pathological diagnosis was confirmed in 155 (63.2%) patients, adenocarcinoma (94.83%) being the predominant type. Metastasis was seen in 204 (83.3%) patients, with liver and abdominal lymph nodes being the frequent sites of metastasis. Most of the patients presented to the surgeons (42.9%) and gastroenterologists (35.9%) at their first visit. Only 89 (26.3%) patients were referred to medical oncologists and 42 (16.7%) of the patients actually received chemotherapy. The patients who received chemotherapy cisplatin and gemcitabine demonstrated partial responses (40%). Common bile duct stricture was seen in 78 patients and stenting was successful in 73 patients. Fourteen (5.7%) patients are alive to date, one is receiving chemotherapy, and another is alive with advanced disease while 10 patients had incidental diagnosis after surgery. Of all 53.9% of patients have died and 38% are lost to follow up. Conclusion: Most of the patients with biliary cancers present late with advanced disease at our referral tertiary care hospital. Minority of the patients received chemotherapy and most of responses were observed with cisplatin and gemcitabine combination or capecitbine based therapy.

KW - Clinical details

KW - Gallbladder cancer

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=75149165945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149165945&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 463

EP - 466

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 3

ER -